K. Nakanishi et al., CONTROL OF RENAL MEDULLARY BLOOD-FLOW BY VASOPRESSIN V-1 AND V-2 RECEPTORS, American journal of physiology. Regulatory, integrative and comparative physiology, 38(1), 1995, pp. 193-200
Experiments were performed in anesthetized renal-denervated rats to de
termine the contribution of renal medullary vasopressin V-1 and V-2 re
ceptor stimulation in the regulation of renal medullary blood flow. Re
nal medullary interstitial infusion of the selective V-1 agonist [Phe(
2), Ile(8), Orn(8)] vasopressin (2 ng . kg(-1). min(-1)) significantly
decreased outer medullary blood flow by 15% and inner medullary blood
flow by 35%, as measured with implanted optical fibers for laser-Dopp
ler flowmetry. Medullary interstitial infusion of equimolar doses of a
rginine vasopressin (AVP) also decreased outer medullary blood flow by
15% but decreased inner medullary blood flow by only 17%, a decrease
significantly less than that during the infusion of the V-1 agonist. T
hese results were confirmed in videomicroscopy experiments on the expo
sed papilla, which demonstrated that the V-1 agonist and AVP decreased
descending and ascending vasa recta capillary red blood cell velocity
and calculated blood flow, with greater decreases during infusion of
the V-1 agonist. In further laser-Doppler flowmetry studies, stimulati
on of V-2 receptors by medullary interstitial infusion of 1-desamino-8
-D-arginine vasopressin (2 ng . kg(-1). min(-1)) or AVP in rats pretre
ated with the vasopressin V-1 receptor antagonist d(CH2)(5)[Tyr(Me)(2)
, Ala-NH2]AVP increased renal medullary blood flow by 16 +/- 3 and 27
+/- 8%, respectively. The present experiments indicate that vasopressi
n V-1 receptor stimulation serves to decrease renal medullary blood fl
ow while V-2 receptor stimulation appears to increase renal medullary
blood flow; however, the net effect of AVP is to decrease renal medull
ary blood flow.